Study on Active Hemostasis Technology in Percutaneous Nephrolithotomy Based on Renal Vascular Distribution and Design and Clinical Application of a New Hemostatic Device: a Randomized Controlled Tial.

Study on Active Hemostasis Technology in Percutaneous Nephrolithotomy Based on Renal Vascular Distribution and Design and Clinical Application of a New Hemostatic Device

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030076

Enrollment

Unknown

Registered

2020-02-22

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis

Interventions

experimental group:tubeless PCNL

control group:routine PCNL

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The subject was diagnosed as kidney stones or upper ureteral stones according to ultrasound or CT scan of urinary system in our hospital. 2. PCNL lithotripsy is proposed for the patient, with definite indications and no absolute contraindications.

Exclusion criteria

Exclusion criteria: Preoperative assessment of surgical risk, anaesthesia risk, cardiovascular and cerebrovascular accident, tolerance to PCNL lithotripsy.

Design outcomes

Primary

Measure	Time frame
hemoglobin;pain;fever;complication rate;hospitalization day;	—

Countries

China

Contacts

Public ContactYuan Yuan

Urology Department, Shenzhen Hospital of the University of Hong Kong

36137980@qq.com+86 13823308565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026